pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 365 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    (measles [strain Edmonston] + mumps [strain Jeryl Lynn] + rubella [strain Wistar]) vaccine
    M-M-R II
    Measles$MRK Merck & Co., Inc.
  • Marketed
    (measles [strain Enders Edmonston] + mumps [strain Jeryl Lynn (Level B)] + rubella [strain Wistar RA 27/3] + varicella [strain Oka/Merck]) vaccine
    ProQuad
    Measles$MRK Merck & Co., Inc.
  • Marketed
    (measles [strain Schwarz] + mumps [strain RIT 4385] + rubella [strain Wistar RA 27/3]) vaccine
    Priorix
    Measles
← prev
page 5 of 13
next →
131
Pain89
Neurology1
GlaxoSmithKline LLC
  • Marketed
    (neomycin sulfate + polymyxin B)
    Neomycin + Polymyxin B Sulfate ((neomycin sulfate + polymyxin B [INN]))
    Bacteriuria X-GEN Pharmaceuticals DJB Inc
  • Marketed
    (nystatin + triamcinolone acetonide)
    Nystatin + Triamcinolone Acetonide ((nystatin [INN] + triamcinolone acetonide))
    Candidiasis Crown Laboratories Inc
  • Marketed
    (penicillin G benzathine + penicillin G procaine)
    Bicillin C-R ((penicillin G benzathine + penicillin G procaine))
    Bacteremia$PFE PFIZER INC
  • Marketed
    (piperacillin sodium + tazobactam sodium)
    Piperacillin Sodium + Tazobactam Sodium ((piperacillin sodium + tazobactam sodium))
    Community-Acquired Bacterial Pneumonia Milla Pharmaceuticals Inc
  • Marketed
    (sofosbuvir + velpatasvir + voxilaprevir)
    Vosevi ((sofosbuvir + velpatasvir + voxilaprevir))
    Hepatitis C$GILD GILEAD SCIENCES, INC.
  • Marketed
    (sofosbuvir + velpatasvir)
    Sofosbuvir + Velpatasvir Asegua ((sofosbuvir + velpatasvir))
    Hepatitis C Asegua Therapeutics LLC
  • Marketed
    (sulfamethoxazole + trimethoprim)
    Sulfamethoxazole + Trimethoprim ((sulfamethoxazole + trimethoprim))
    Enteritis Vista Pharmaceuticals Inc
  • Marketed
    Abrysvo
    Abrysvo
    Respiratory Syncytial Virus (RSV) Infections$PFE PFIZER INC
  • Marketed
    Arexvy
    Arexvy
    Respiratory Syncytial Virus (RSV) Infections GlaxoSmithKline Biopharmaceuticals inc
  • Marketed
    Augmentin
    Augmentin ((amoxicillin + clavulanate potassium))
    Skin And Skin Structure Infections (SSSI) Caused By Bacteria NeoPharma Inc
  • Marketed
    Bicillin L A
    Bicillin L A (penicillin G benzathine)
    Upper Respiratory Tract Infections by Streptococcus pyogenes$PFE PFIZER INC
  • Marketed
    Comirnaty KP.2
    Omicron KP.2-adapted monovalent COVID-19 vaccine
    Coronavirus Disease 2019 (COVID-19) BioNTech US Inc
  • Marketed
    Comirnaty LP.8.1
    Comirnaty LP.8.1
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Marketed
    Coronavirus Disease 2019 (COVID-19) KP.2 vaccine
    Spikevax KP.2
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • Marketed
    Coronavirus Disease 2019 (COVID-19) vaccine 1
    Covid-19 Vaccine (mivalsecovatein [INN])
    Coronavirus Disease 2019 (COVID-19)$NVAX NOVAVAX INC
  • Marketed
    Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
    Spikevax Omicron XBB.1.5
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • Marketed
    Cyfendus
    Cyfendus
    Anthrax$EBS Emergent BioSolutions Inc.
  • Marketed
    Ebola Zaire vaccine
    Ervebo
    Ebolavirus Infections (Ebola Hemorrhagic Fever)$MRK Merck & Co., Inc.
  • Marketed
    Eraxis
    Eraxis (anidulafungin)
    Abdominal Abscess$PFE PFIZER INC
  • Marketed
    Eryped
    E.E.S. (erythromycin [INN])
    Acute Intestinal Amoebiasis Carnegie Pharmaceuticals LLC
  • Marketed
    Fluad (Trivalent)
    Fluad
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Marketed
    Fluarix
    Fluarix
    Influenza A Virus, H1N1 Subtype Infections GlaxoSmithKline Consumer Healthcare LP
  • Marketed
    Fluarix Quadrivalent
    Fluarix Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections GlaxoSmithKline Consumer Healthcare LP
  • Marketed
    Flublok
    Flublok
    Influenza A Virus, H1N1 Subtype Infections Protein Sciences Corp
  • Marketed
    Fluzone High Dose
    Fluzone High Dose
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Biologics LLC
  • Marketed
    Fluzone Intradermal (Quadrivalent)
    Fluzone Intradermal Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Inc
  • Marketed
    Kimyrsa
    Kimyrsa (oritavancin [INN])
    Skin And Skin Structure Infections (SSSI) Caused By Bacteria Melinta Therapeutics LLC